Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronidazole and Ivermectin in hospitalized patients with COVID-19
IRCT20180612040068N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of metronidazole and ivermectin in coronavirus disease 2019 (COVID-19), sponsored by Shiraz University of Medical Sciences. Started Mar 2021; status: completed.
02
Drugs
metronidazoleivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20180612040068N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180612040068N1.